EDX Medical Group PLC Ordinary Shares EDX
Trading Information
- Previous Close Price
- GBX7.75
- Day Range
- GBX7.50–10.00
- 52-Week Range
- GBX6.00–13.00
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 431.37M
- Market Cap
- GBX3.99B
- Volume/Avg
- 373,295 / 60,303
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 90.64
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
EDX Medical Group PLC is principally engaged in the business of creating health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical services segment. Geographically, all revenue was derived from the United Kingdom.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 16
- Website
- https://www.edxmedical.co.uk
Valuation
Metric | EDX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 14.62 |
Price/Sales | 90.64 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | EDX |
|---|---|
Quick Ratio | 1.80 |
Current Ratio | 1.94 |
Interest Coverage | −1,524.58 |
Quick Ratio
EDX
Profitability
Metric | EDX |
|---|---|
Return on Assets (Normalized) | −147.83% |
Return on Equity (Normalized) | −240.03% |
Return on Invested Capital (Normalized) | −224.14% |
Return on Assets
EDX
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|<!!XWG$ | LOCK|VN | $267B | |||
| Danaher Corp DHR | LOCK|#Gv>%Wq> | LOCK|?#F | $165B | |||
| IDEXX Laboratories Inc IDXX | LOCK|f@FM!%v# | LOCK|>! | $56B | |||
| Agilent Technologies Inc A | LOCK|c#RZzdq^ | LOCK|@#& | $51B | |||
| Waters Corp WAT | LOCK|Cv$dHZj | LOCK|hp | $47B | |||
| IQVIA Holdings Inc IQV | LOCK|T^#wfh^ | LOCK|$k^<h | $46B | |||
| Mettler-Toledo International Inc MTD | LOCK|gN@%!LYX | LOCK|s@&t | $35B | |||
| Illumina Inc ILMN | LOCK|^QXTD< | LOCK|RGs&> | $33B | |||
| Labcorp Holdings Inc LH | LOCK|sL&@k!& | LOCK|bW!<X | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|$JgQ!< | LOCK|z?R$& | $29B |
United States